Cancer is the scourge of the modern era. Getting a cancer diagnosis is devastating news and for many, it puts them in a battle for their very lives against this disease.
Naturally, many health experts and medical professionals around the world are eagerly trying their best to find an effective method of treatment that won't take the physical toll on patients that radiation and chemotherapy do. One of the most well-known (and somewhat controversial) options is vitamin B17.
The History of B-17
Back in the 1970s, the war on cancer was in full swing at New York's Sloan-Kettering research center. Ralph Moss joined the facility in 1974, right when the focus of the research was on testing Laetrile, a form of vitamin B17.
This was Moss' first major gig, and he'd landed himself right in the middle of some truly groundbreaking research. Unfortunately, Laetrile was deemed "potentially harmful," and Sloan-Kettering's Board of Directors ordered that the project be cast aside.
Moss, however, felt that Laetrile's potential was being swept under the rug, and he called a press conference of his own during which he accused his employers of conspiring to cover up the research around B17. Nonetheless, Laetrile was banned in the United States shortly thereafter and has remained so ever since.
Why Was It Banned?
According to a report by the FDA, B17 is considered highly toxic. This conclusion, however, remains up for debate with many physicians.
G. Edward Griffin, the author of World Without Cancer, has studied B17 extensively and says that he has "found no statements of demonstrated pharmacological harmfulness of amygdalin to human beings at any dosages recommended or employed by medical doctors in the United States and abroad."
Although B17 remains banned from the U.S. for the time being, researchers around the world continue to find positive applications for it.
In 2003, researchers discovered that amygdalin (another name for B17) from peach pits had an influence on tumor growth.
Another study from 2006 found that B17 triggers a process of cell death in cancer cells.
Researchers also found promising results using B17 to treat cervical cancer in 2013, and another group also had success with bladder cancer tumors in 2014.
What You Can Do
Currently, B17 remains illegal in the United States, and we do not recommend that you break the law by trying to procure some through illegal means. Not only is it a crime, but you also can't always trust the authenticity or quality of the medicine provided by these shady dealers.
Ralph Morris, the former Sloan-Kettering employee mentioned earlier, has also started a petition to get Sloan-Kettering to formally acknowledge the positive results of B17. If you're interested, you can sign that petition here.
If you're interested in pursuing B17 as a treatment option, we strongly advise that you speak with your doctor to learn more. Always consult your physician before starting any new treatment.
Don't forget to SHARE this vital information with your family and friends.
H/T: David Wolfe